secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2023-10-04T23:59:59+00:00
Accession:  0001493152-23-035706
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions closes $4.38M public offering, net proceeds ~$3.35M
-----------------------------------------------------------------------------

- Gross proceeds of $4.378M from offering of 2.23M common shares, 5.73M Series E preferred, and warrants to purchase up to 7.96M shares.
- Net proceeds of approximately $3.35M after underwriting discounts and expenses, for general corporate purposes and working capital.
- Series E Preferred Stock is convertible 1:1 into common stock, no dividend rights except as paid on common, limited voting rights.
- CFO Spiro Sakiris purchased 112,727 Class A Units and director Christopher Towers purchased 9,090 Class A Units on same terms.
- Underwriter's overallotment option partially exercised; warrants exercisable only after Nasdaq shareholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223035706/0001493152-23-035706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223035706/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-035706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer